This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zietz, C. Articles by Löhrs, U. Search for Related Content PubMed PubMed Citation Articles by Zietz, C. Articles by Löhrs, U.

(American Journal of Pathology. 2001;159:963-970.)
© 2001 American Society for Investigative Pathology

Regular Articles

Inverse Relation of Fas-Ligand and Tumor-Infiltrating Lymphocytes in Angiosarcoma

Indications of Apoptotic Tumor Counterattack

Christian Zietz^*, Ulrich Rumpler^*, Michael Stürzl and Udo Löhrs^*

From the Institute of Pathology,^*
Ludwig Maximilians University, Munich; and the Institute of Molecular Virology,
GSF-National Research Center for Environment and Health, Neuherberg, Germany

Fas and Fas-L regulate immune responses through the induction of cell death. Fas-L is commonly expressed in activated immune cells and in the endothelium. In the latter it contributes to the inhibition of transvascular cell migration by the induction of apoptosis in Fas-bearing lymphocytes. Here we investigated whether the Fas/Fas-L system may regulate lymphocyte invasion into angiosarcomas. Fas and Fas-L expression was quantitatively determined in different grade angiosarcomas (n = 40) and related to the number of extravasated tumor-infiltrating lymphocytes (TILs). Fas expression was detected in <50% of the cases. In positive tumors both the number of Fas-positive cells and the staining intensity were highly variable and did not correlate with the number of TILs, the mean time of survival, and the histopathological tumor grade. By contrast, Fas-L expression was detected in >70% of the cases and the relative numbers of Fas-L-positive cells correlated inversely with the numbers of CD3- and CD8-positive TILs (P 0.004). The survival times of patients with high Fas-L-expressing angiosarcomas were significantly reduced as compared to patients with low Fas-L-expressing tumors. Our results show that angiosarcomas with low Fas-L expression are characterized by numerous TILs, whereas sarcomas with high Fas-L expression show significantly reduced numbers of TILs. These results suggest that the Fas/Fas-L system may repress TIL invasion into angiosarcoma and by this may contribute to the evasion of the anti-tumor immune surveillance of angiosarcoma in the course of an apoptotic tumor counterattack mechanism.